SlideShare a Scribd company logo
CT Calcium ScoringCT Calcium Scoring
Dr.Sahar Gamal El-Din , CBCCTDr.Sahar Gamal El-Din , CBCCT
Background
• Approximately 50% of acute MI occur inApproximately 50% of acute MI occur in
people without any history of CAD.people without any history of CAD.
• Coronary atherosclerosis is a slow progressiveCoronary atherosclerosis is a slow progressive
disease that often goes unrecognized until thedisease that often goes unrecognized until the
person develops symptoms.person develops symptoms.
• What is needed is a way to identifyWhat is needed is a way to identify
asymptomatic people who are at high risk forasymptomatic people who are at high risk for
CV events early in their disease process.CV events early in their disease process.
• MI usually occurs in patients who have aMI usually occurs in patients who have a
mild or moderate CA stenosis thatmild or moderate CA stenosis that
develops plaque rupture & leads to andevelops plaque rupture & leads to an
acute thrombosis.acute thrombosis.
• These mild to moderate coronary lesionsThese mild to moderate coronary lesions
may not cause symptoms and/or may notmay not cause symptoms and/or may not
cause enough ischemia to be picked upcause enough ischemia to be picked up
during a routine stress test.during a routine stress test.
• During the early stages of coronaryDuring the early stages of coronary
atherosclerosis calcium starts toatherosclerosis calcium starts to
accumulate within the plaque.accumulate within the plaque.
• As the atherosclerotic process progressesAs the atherosclerotic process progresses
the amount of calcification increases.the amount of calcification increases.
• During the advanced stages ofDuring the advanced stages of
atherosclerosis a large amount ofatherosclerosis a large amount of
coronary calcification may be present.coronary calcification may be present.
Coronary Disease Progression
Calcified Plaque Detected by CT
• Atherosclerosis is the only diseaseAtherosclerosis is the only disease
process known to cause calcium toprocess known to cause calcium to
deposit in coronary artery walls.deposit in coronary artery walls.
• Calcification is not a degenerativeCalcification is not a degenerative
disease, it is not a part of the “normal”disease, it is not a part of the “normal”
aging process.aging process.
• Calcium is not found in normal CA.Calcium is not found in normal CA.
• Since calcium deposits start to developSince calcium deposits start to develop
during the early stages of atherosclerosisduring the early stages of atherosclerosis
and if we are able to identify theand if we are able to identify the
presence of calcium we are able topresence of calcium we are able to
identify preclinical coronary arteryidentify preclinical coronary artery
disease during the asymptomatic stage.disease during the asymptomatic stage.
• This can allow for the implementation ofThis can allow for the implementation of
early aggressive risk factor reduction.early aggressive risk factor reduction.
• Calcification can be seen with fluoroscopyCalcification can be seen with fluoroscopy
and on chest x-ray.and on chest x-ray.
• Computed tomography allowsComputed tomography allows
quantification of this calcium.quantification of this calcium.
• The amount of calcium deposited inThe amount of calcium deposited in
coronary arteries is added up and a “score” iscoronary arteries is added up and a “score” is
given.given.
• The amount of calcium in the coronaryThe amount of calcium in the coronary
arteries varies considerably with age andarteries varies considerably with age and
gender.gender.
• For this reason, coronary calcium scores areFor this reason, coronary calcium scores are
presented as percentile scores that can tellpresented as percentile scores that can tell
how much calcium you have compared tohow much calcium you have compared to
other men or women of your age.other men or women of your age.
• higher than the 75th percentile ishigher than the 75th percentile is
considered high risk, irrespective of theconsidered high risk, irrespective of the
score, and indicates prematurescore, and indicates premature
atherosclerosis.atherosclerosis.
• Unlike global risk scores such as theUnlike global risk scores such as the
Framingham Risk Score, which provide cardio-Framingham Risk Score, which provide cardio-
vascular risk estimates based on mean risk factorvascular risk estimates based on mean risk factor
distributions across a population, the CCS is adistributions across a population, the CCS is a
direct marker of atherosclerosis in an individualdirect marker of atherosclerosis in an individual
patient.patient.
• As such, it provides an assessment of the burdenAs such, it provides an assessment of the burden
of coronary atherosclerosis, reflecting theof coronary atherosclerosis, reflecting the
integrated lifetime effect of all risk factors in anintegrated lifetime effect of all risk factors in an
individual patient.individual patient.
CCS Protocol
• CAC is detected using a standardized protocolCAC is detected using a standardized protocol
involving :involving :
• Prospective ECG-triggered axial scanning, withProspective ECG-triggered axial scanning, with
a slice thickness of 3mm.a slice thickness of 3mm.
• Standard tube voltage is 120 kV, with tubeStandard tube voltage is 120 kV, with tube
current set at 120 to 150 mAs, which shouldcurrent set at 120 to 150 mAs, which should
result in acceptably low levels of radiationresult in acceptably low levels of radiation
exposure (1 to 2 mSv).exposure (1 to 2 mSv).
MethodsMethods
• Agatston Score :Agatston Score :Traditional methodTraditional method
(EBCT : MDCT)(EBCT : MDCT)
• Volume Score :Volume Score : Plaque area x slicePlaque area x slice
thickness (mmthickness (mm³³))
• Mass Score :Mass Score : Plaque volume x meanPlaque volume x mean
plaque density .plaque density .
• The method is based on the maximum x-ray
attenuation coefficient, or CT number
(measured in Hounsfield units [HU]), and
the area of calcium deposits.
• First, calcified lesions are identified on CT
images by applying a threshold of 130 HU
to the entire image set; tissues with
densities equal to or greater than the
threshold are considered to correspond to
calcium.
Agatston ScoreAgatston Score
• For each coronary artery, i, a region of
interest (ROI) is drawn around each
calcified lesion, j.
• The maximum CT number, CTmax ij , of
the ROI is determined and used to assign
a weighting factor, wij.
• The area, Aij, of the ROI is also
determined.
• The Agatston score, Sij, is computed as
the product of the weighting factor and
the area:
Sij = wij x Aij
Where :
• w ij = 1 if CTijmax 130 - 199 HU
2 if CTijmax 200 - 299 HU
3 if CTijmax 300 - 399 HU
4 if CTijmax > 400 HU
• The score for all lesions in all coronary
arteries is summed to determine the total
calcium burden:
Stot = Σ Sij
Ct calcium scoring 1
The Calcium ScaleThe Calcium Scale
The calcium scale is a linear scale with 4The calcium scale is a linear scale with 4
calcium score categories:calcium score categories:
00 NormalNormal
1–991–99 MildMild
100–400100–400 ModerateModerate
>400>400 SevereSevere
Ct calcium scoring 1
• Variations according to sex and ethnicity haveVariations according to sex and ethnicity have
been described.been described.
• In the Multi-Ethnic Study of AtherosclerosisIn the Multi-Ethnic Study of Atherosclerosis
(MESA)(MESA) of 6,110 asymptomatic patients, menof 6,110 asymptomatic patients, men
had higher calcium levels than women, and thehad higher calcium levels than women, and the
amount and prevalence of calcium continuallyamount and prevalence of calcium continually
increased with increasing age .increased with increasing age .
• A calcium score of 175 may be average for a 65A calcium score of 175 may be average for a 65
year old male but grossly abnormal for a 55year old male but grossly abnormal for a 55
year old female.year old female.
Circulation 2006;113:30–7Circulation 2006;113:30–7
Distribution - menDistribution - men
Age Ca Score
< 40 0
40 -49 0
50-54 5
55-59 36
60-64 95
65-69 201
70-74 302
> 74 521
Distribution - womenDistribution - women
Age Ca Score
< 40 0
40 -49 0
50-54 0
55-59 0
60-64 0
65-69 8
70-74 28
> 74 149
• In men, Caucasians and Hispanics had the firstIn men, Caucasians and Hispanics had the first
and second highest scores, respectively; blacksand second highest scores, respectively; blacks
had the lowest scores at the younger ages, andhad the lowest scores at the younger ages, and
Chinese had the lowest scores at the older ages.Chinese had the lowest scores at the older ages.
• In women, Caucasians had the highest scores,In women, Caucasians had the highest scores,
Chinese and blacks had intermediate scores, andChinese and blacks had intermediate scores, and
Hispanics had the lowest score except for ChineseHispanics had the lowest score except for Chinese
in the oldest age group.in the oldest age group.
•What does CCS “0” mean?
• One may still have non-calcifiedOne may still have non-calcified
atherosclerotic plaque .atherosclerotic plaque .
• Multiple studies have shown only a 0.11 %Multiple studies have shown only a 0.11 %
annual event rate and 1.1% 10 year risk inannual event rate and 1.1% 10 year risk in
asymptomatic patients with 0 CCS.asymptomatic patients with 0 CCS.
•Advantages of CCS
• Rapid .Rapid .
• Does not require contrast.Does not require contrast.
• Low radiation dose .Low radiation dose .
• Reproducible.Reproducible.
• Powerful prognostic data.Powerful prognostic data.
• Disadvantages of CCS :Disadvantages of CCS :
• CostCost
• Radiation exposureRadiation exposure
Coronary Calcium and Clinical OutcomesCoronary Calcium and Clinical Outcomes
• OVERALL:OVERALL:
– 15 studies published15 studies published
– Age range 41- 85 years oldAge range 41- 85 years old
– Approximately 15,000 patientsApproximately 15,000 patients
– All studies have reported that coronaryAll studies have reported that coronary
calcium predicts CV disease eventscalcium predicts CV disease events
independently of and more accuratelyindependently of and more accurately
than traditional risk factors.than traditional risk factors.
• At 2004 a study was carried out inAt 2004 a study was carried out in
Netherlands:Netherlands:
• From 2,032 people ages 55 to 85, with aFrom 2,032 people ages 55 to 85, with a
mean age of 77, who underwent CTmean age of 77, who underwent CT
calcium scoring between 1997 and 2000calcium scoring between 1997 and 2000
• 0 -100 : 47%0 -100 : 47%
• 100 -500 : 26%100 -500 : 26%
• >500 : 27%>500 : 27%
• The mean duration of follow-up was 2.7The mean duration of follow-up was 2.7
years, during which time 92 subjectsyears, during which time 92 subjects
Ct calcium scoring 1
• Calcium scores 101-500 :Calcium scores 101-500 : double risk ofdouble risk of
mortality.mortality.
• Calcium scores over 500 :Calcium scores over 500 : 2.7 times2.7 times
increased risk of mortality.increased risk of mortality.
• The increase in mortality :The increase in mortality :
between the lowest and the middlebetween the lowest and the middle
category of calcium scores (0-100 and 101-category of calcium scores (0-100 and 101-
500) : 12.3%500) : 12.3%
 between the middle and the highestbetween the middle and the highest
scores (101-500 and >500) : 23.7%scores (101-500 and >500) : 23.7%
Integrating the Calcium Score withIntegrating the Calcium Score with
the Framingham Risk Score (FRS)the Framingham Risk Score (FRS)
• 2004, Johns Hopkins University2004, Johns Hopkins University
calculated the Framingham scores of 5,324calculated the Framingham scores of 5,324
asymptomatic individualsasymptomatic individuals
• Stratified into low-risk, intermediate-risk, andStratified into low-risk, intermediate-risk, and
high-risk groupshigh-risk groups
― Low-riskLow-risk is defined as a 10 year risk of < 10%,is defined as a 10 year risk of < 10%,
― intermediate-riskintermediate-risk is defined as a 10 year risk of 10is defined as a 10 year risk of 10
to 20%to 20%
― high-riskhigh-risk is defined as a 10 year risk > 20%is defined as a 10 year risk > 20%
• Underwent CT coronary artery scanningUnderwent CT coronary artery scanning
Framingham Score 10 yr. event riskFramingham Score 10 yr. event risk
recalculated according to CCS rangerecalculated according to CCS range
• CLASS IIaCLASS IIa
• Measurement of CCS is reasonable forMeasurement of CCS is reasonable for
cardiovascular risk assessment in asymptomaticcardiovascular risk assessment in asymptomatic
adults at intermediate risk (10% to 20% 10-yearadults at intermediate risk (10% to 20% 10-year
risk).risk). (Level of Evidence: B) .(Level of Evidence: B) .
2010 ACCF/AHA Guideline2010 ACCF/AHA Guideline
RECOMMENDATIONS FOR CALCIUMRECOMMENDATIONS FOR CALCIUM
SCORING METHODSSCORING METHODS
• CLASS IIbCLASS IIb
• Measurement of CCS may be reasonable forMeasurement of CCS may be reasonable for
cardiovascular risk assessment in persons atcardiovascular risk assessment in persons at
low to intermediate risk (6% to 10% 10-yearlow to intermediate risk (6% to 10% 10-year
risk).risk). (Level of Evidence: B)(Level of Evidence: B)
• CLASS III: NO BENEFITCLASS III: NO BENEFIT
• Persons at low risk (<6% 10-year risk) shouldPersons at low risk (<6% 10-year risk) should
not undergo CCS measurement fornot undergo CCS measurement for
cardiovascular risk assessment.cardiovascular risk assessment.
(Level of Evidence: B).(Level of Evidence: B).
Detection of CAD/Risk Assessment inDetection of CAD/Risk Assessment in
Asymptomatic Patients Without Known CADAsymptomatic Patients Without Known CAD
IndicationIndication Appropriate Use Score (1–9)Appropriate Use Score (1–9)
Global CHDGlobal CHD
Risk EstimateRisk Estimate
LowLow IntermediateIntermediate HighHigh
Family history of
premature CHD
A (7)A (7)
Asymptomatic
No known CAD
I (2)I (2) A (7)A (7) U (4)U (4)
JCCT (2010) 4, 407.e1–407.e33JCCT (2010) 4, 407.e1–407.e33
ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI
/SCMR 2010 Appropriate Use Criteria
The 2013 ACC/AHA CholesterolThe 2013 ACC/AHA Cholesterol
and the 2013 ACC/AHA Risk Guidelinesand the 2013 ACC/AHA Risk Guidelines
• Created an entirely risk factor–basedCreated an entirely risk factor–based
pooled cohort equation untested bypooled cohort equation untested by
randomized clinical trials, using the samerandomized clinical trials, using the same
risk factors as the 2010 version but withrisk factors as the 2010 version but with
different weightings, now modified bydifferent weightings, now modified by
race.race.
• They downgraded CCS to a Class IIbThey downgraded CCS to a Class IIb
recommendation.recommendation.
ConclusionConclusion
• Despite the remarkable data supporting the prime
role of CCS in risk assessment of the
intermediate-risk population & considering it a
more potent predictor of CAD than risk factors for
atherosclerosis , CCS has not been incorporated
into the mainstream of clinical cardiology and has
been downgraded in the 2013 guidelines.
• As the data continue to accumulate with follow-
up periods up to 15 years, accompanied by
increasing public & physician awareness, the
importance of CCS will be more universally
accepted
Ct calcium scoring 1

More Related Content

PPTX
CT calcium score.pptx
PDF
Coronary artery calcium scoring IDoR 2018
PPTX
Coronary ct angiography
PPTX
PPT
Cardiac ct ccta
PPTX
Ct angio in cardiology
PPTX
CT Coronary angiography
CT calcium score.pptx
Coronary artery calcium scoring IDoR 2018
Coronary ct angiography
Cardiac ct ccta
Ct angio in cardiology
CT Coronary angiography

What's hot (20)

PPTX
PPTX
Radiation Safety In The Cath Lab
PPTX
PPTX
Cardiac Magnetic Resonance Imaging
PPTX
Diagnostic catheters for coronary angiography
PPTX
LEFT VENTRICULOGRAPHY.pptx
PPTX
Intravenous Ultrasound
PPTX
Intravascular Ultrasound (IVUS)
PPTX
Aortic interventions
PPT
Contrast Agents in Angiography
PPTX
PPTX
Coronary CT
PPTX
Catheters $ guidewires
PPTX
Peripheral angiography
PPTX
PET scan in cardiac imaging
PPT
CT Coronary Angiography (CTCA)
PPTX
Cardiac CT
PPTX
Different Coronary stent design PPT
PPT
Cardiac MRI
PPTX
Ct coronary angiography edited 1st
Radiation Safety In The Cath Lab
Cardiac Magnetic Resonance Imaging
Diagnostic catheters for coronary angiography
LEFT VENTRICULOGRAPHY.pptx
Intravenous Ultrasound
Intravascular Ultrasound (IVUS)
Aortic interventions
Contrast Agents in Angiography
Coronary CT
Catheters $ guidewires
Peripheral angiography
PET scan in cardiac imaging
CT Coronary Angiography (CTCA)
Cardiac CT
Different Coronary stent design PPT
Cardiac MRI
Ct coronary angiography edited 1st
Ad

Similar to Ct calcium scoring 1 (20)

PPT
CT Calcium Scoring Lecture Overview Powerpoint
PDF
Thorax cardio coeur heart evaluation asymptomatic smoker p douek
PDF
Chris ellis calcium scoring cta
PPT
Role of CT Scan Calcium scoring in Coronary Artery Disease
PPT
Coronary Calcium and other CVD Risk Biomarkers: From Epidemiology to Comparat...
PPT
214 how can calcium score improve your practice
PPT
214 how can calcium score improve your practice
PDF
50 002
PPT
239 coronary artery calcium
PPT
Ebt rumberger- ohio state u- part 21
PPT
PPS
3rd vulnerable plaque rumberg 3 16-02 2
PPT
3rd vulnerable plaque rumberg 3 16-02 2
PPS
3rd vulnerable plaque rumberg 3 16-02 2
PPT
3rd vulnerable plaque rumberg 3 16-02 2
CT Calcium Scoring Lecture Overview Powerpoint
Thorax cardio coeur heart evaluation asymptomatic smoker p douek
Chris ellis calcium scoring cta
Role of CT Scan Calcium scoring in Coronary Artery Disease
Coronary Calcium and other CVD Risk Biomarkers: From Epidemiology to Comparat...
214 how can calcium score improve your practice
214 how can calcium score improve your practice
50 002
239 coronary artery calcium
Ebt rumberger- ohio state u- part 21
3rd vulnerable plaque rumberg 3 16-02 2
3rd vulnerable plaque rumberg 3 16-02 2
3rd vulnerable plaque rumberg 3 16-02 2
3rd vulnerable plaque rumberg 3 16-02 2
Ad

More from Sahar Gamal (9)

PPTX
Ra cvd
PPTX
In stent restenosis
PPT
Non coronary cardiac CT
PPTX
Cardiac ct ccta2
PPT
CA anomalies on CT angiography
PPT
Resistant hypertension
PPT
Hypertensive emergenciec & urgencies
PPT
PPT
Coronary artery anomalies on CTA
Ra cvd
In stent restenosis
Non coronary cardiac CT
Cardiac ct ccta2
CA anomalies on CT angiography
Resistant hypertension
Hypertensive emergenciec & urgencies
Coronary artery anomalies on CTA

Recently uploaded (20)

PPTX
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx
PDF
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
PPTX
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
PPTX
Fundamentals of human energy transfer .pptx
PDF
CT Anatomy for Radiotherapy.pdf eryuioooop
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PDF
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
PPTX
Slider: TOC sampling methods for cleaning validation
PPTX
CME 2 Acute Chest Pain preentation for education
DOCX
NEET PG 2025 | Pharmacology Recall: 20 High-Yield Questions Simplified
PPTX
Acid Base Disorders educational power point.pptx
PPTX
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
PPTX
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
PDF
Khadir.pdf Acacia catechu drug Ayurvedic medicine
PPT
Obstructive sleep apnea in orthodontics treatment
PPTX
Respiratory drugs, drugs acting on the respi system
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPT
Breast Cancer management for medicsl student.ppt
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
Fundamentals of human energy transfer .pptx
CT Anatomy for Radiotherapy.pdf eryuioooop
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
Slider: TOC sampling methods for cleaning validation
CME 2 Acute Chest Pain preentation for education
NEET PG 2025 | Pharmacology Recall: 20 High-Yield Questions Simplified
Acid Base Disorders educational power point.pptx
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
Khadir.pdf Acacia catechu drug Ayurvedic medicine
Obstructive sleep apnea in orthodontics treatment
Respiratory drugs, drugs acting on the respi system
MENTAL HEALTH - NOTES.ppt for nursing students
Breast Cancer management for medicsl student.ppt
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer

Ct calcium scoring 1

  • 1. CT Calcium ScoringCT Calcium Scoring Dr.Sahar Gamal El-Din , CBCCTDr.Sahar Gamal El-Din , CBCCT
  • 2. Background • Approximately 50% of acute MI occur inApproximately 50% of acute MI occur in people without any history of CAD.people without any history of CAD. • Coronary atherosclerosis is a slow progressiveCoronary atherosclerosis is a slow progressive disease that often goes unrecognized until thedisease that often goes unrecognized until the person develops symptoms.person develops symptoms. • What is needed is a way to identifyWhat is needed is a way to identify asymptomatic people who are at high risk forasymptomatic people who are at high risk for CV events early in their disease process.CV events early in their disease process.
  • 3. • MI usually occurs in patients who have aMI usually occurs in patients who have a mild or moderate CA stenosis thatmild or moderate CA stenosis that develops plaque rupture & leads to andevelops plaque rupture & leads to an acute thrombosis.acute thrombosis. • These mild to moderate coronary lesionsThese mild to moderate coronary lesions may not cause symptoms and/or may notmay not cause symptoms and/or may not cause enough ischemia to be picked upcause enough ischemia to be picked up during a routine stress test.during a routine stress test.
  • 4. • During the early stages of coronaryDuring the early stages of coronary atherosclerosis calcium starts toatherosclerosis calcium starts to accumulate within the plaque.accumulate within the plaque. • As the atherosclerotic process progressesAs the atherosclerotic process progresses the amount of calcification increases.the amount of calcification increases. • During the advanced stages ofDuring the advanced stages of atherosclerosis a large amount ofatherosclerosis a large amount of coronary calcification may be present.coronary calcification may be present.
  • 6. • Atherosclerosis is the only diseaseAtherosclerosis is the only disease process known to cause calcium toprocess known to cause calcium to deposit in coronary artery walls.deposit in coronary artery walls. • Calcification is not a degenerativeCalcification is not a degenerative disease, it is not a part of the “normal”disease, it is not a part of the “normal” aging process.aging process. • Calcium is not found in normal CA.Calcium is not found in normal CA.
  • 7. • Since calcium deposits start to developSince calcium deposits start to develop during the early stages of atherosclerosisduring the early stages of atherosclerosis and if we are able to identify theand if we are able to identify the presence of calcium we are able topresence of calcium we are able to identify preclinical coronary arteryidentify preclinical coronary artery disease during the asymptomatic stage.disease during the asymptomatic stage. • This can allow for the implementation ofThis can allow for the implementation of early aggressive risk factor reduction.early aggressive risk factor reduction.
  • 8. • Calcification can be seen with fluoroscopyCalcification can be seen with fluoroscopy and on chest x-ray.and on chest x-ray. • Computed tomography allowsComputed tomography allows quantification of this calcium.quantification of this calcium.
  • 9. • The amount of calcium deposited inThe amount of calcium deposited in coronary arteries is added up and a “score” iscoronary arteries is added up and a “score” is given.given. • The amount of calcium in the coronaryThe amount of calcium in the coronary arteries varies considerably with age andarteries varies considerably with age and gender.gender. • For this reason, coronary calcium scores areFor this reason, coronary calcium scores are presented as percentile scores that can tellpresented as percentile scores that can tell how much calcium you have compared tohow much calcium you have compared to other men or women of your age.other men or women of your age.
  • 10. • higher than the 75th percentile ishigher than the 75th percentile is considered high risk, irrespective of theconsidered high risk, irrespective of the score, and indicates prematurescore, and indicates premature atherosclerosis.atherosclerosis.
  • 11. • Unlike global risk scores such as theUnlike global risk scores such as the Framingham Risk Score, which provide cardio-Framingham Risk Score, which provide cardio- vascular risk estimates based on mean risk factorvascular risk estimates based on mean risk factor distributions across a population, the CCS is adistributions across a population, the CCS is a direct marker of atherosclerosis in an individualdirect marker of atherosclerosis in an individual patient.patient. • As such, it provides an assessment of the burdenAs such, it provides an assessment of the burden of coronary atherosclerosis, reflecting theof coronary atherosclerosis, reflecting the integrated lifetime effect of all risk factors in anintegrated lifetime effect of all risk factors in an individual patient.individual patient.
  • 12. CCS Protocol • CAC is detected using a standardized protocolCAC is detected using a standardized protocol involving :involving : • Prospective ECG-triggered axial scanning, withProspective ECG-triggered axial scanning, with a slice thickness of 3mm.a slice thickness of 3mm. • Standard tube voltage is 120 kV, with tubeStandard tube voltage is 120 kV, with tube current set at 120 to 150 mAs, which shouldcurrent set at 120 to 150 mAs, which should result in acceptably low levels of radiationresult in acceptably low levels of radiation exposure (1 to 2 mSv).exposure (1 to 2 mSv).
  • 13. MethodsMethods • Agatston Score :Agatston Score :Traditional methodTraditional method (EBCT : MDCT)(EBCT : MDCT) • Volume Score :Volume Score : Plaque area x slicePlaque area x slice thickness (mmthickness (mm³³)) • Mass Score :Mass Score : Plaque volume x meanPlaque volume x mean plaque density .plaque density .
  • 14. • The method is based on the maximum x-ray attenuation coefficient, or CT number (measured in Hounsfield units [HU]), and the area of calcium deposits. • First, calcified lesions are identified on CT images by applying a threshold of 130 HU to the entire image set; tissues with densities equal to or greater than the threshold are considered to correspond to calcium. Agatston ScoreAgatston Score
  • 15. • For each coronary artery, i, a region of interest (ROI) is drawn around each calcified lesion, j. • The maximum CT number, CTmax ij , of the ROI is determined and used to assign a weighting factor, wij. • The area, Aij, of the ROI is also determined.
  • 16. • The Agatston score, Sij, is computed as the product of the weighting factor and the area: Sij = wij x Aij Where : • w ij = 1 if CTijmax 130 - 199 HU 2 if CTijmax 200 - 299 HU 3 if CTijmax 300 - 399 HU 4 if CTijmax > 400 HU
  • 17. • The score for all lesions in all coronary arteries is summed to determine the total calcium burden: Stot = Σ Sij
  • 19. The Calcium ScaleThe Calcium Scale The calcium scale is a linear scale with 4The calcium scale is a linear scale with 4 calcium score categories:calcium score categories: 00 NormalNormal 1–991–99 MildMild 100–400100–400 ModerateModerate >400>400 SevereSevere
  • 21. • Variations according to sex and ethnicity haveVariations according to sex and ethnicity have been described.been described. • In the Multi-Ethnic Study of AtherosclerosisIn the Multi-Ethnic Study of Atherosclerosis (MESA)(MESA) of 6,110 asymptomatic patients, menof 6,110 asymptomatic patients, men had higher calcium levels than women, and thehad higher calcium levels than women, and the amount and prevalence of calcium continuallyamount and prevalence of calcium continually increased with increasing age .increased with increasing age . • A calcium score of 175 may be average for a 65A calcium score of 175 may be average for a 65 year old male but grossly abnormal for a 55year old male but grossly abnormal for a 55 year old female.year old female. Circulation 2006;113:30–7Circulation 2006;113:30–7
  • 22. Distribution - menDistribution - men Age Ca Score < 40 0 40 -49 0 50-54 5 55-59 36 60-64 95 65-69 201 70-74 302 > 74 521
  • 23. Distribution - womenDistribution - women Age Ca Score < 40 0 40 -49 0 50-54 0 55-59 0 60-64 0 65-69 8 70-74 28 > 74 149
  • 24. • In men, Caucasians and Hispanics had the firstIn men, Caucasians and Hispanics had the first and second highest scores, respectively; blacksand second highest scores, respectively; blacks had the lowest scores at the younger ages, andhad the lowest scores at the younger ages, and Chinese had the lowest scores at the older ages.Chinese had the lowest scores at the older ages. • In women, Caucasians had the highest scores,In women, Caucasians had the highest scores, Chinese and blacks had intermediate scores, andChinese and blacks had intermediate scores, and Hispanics had the lowest score except for ChineseHispanics had the lowest score except for Chinese in the oldest age group.in the oldest age group.
  • 25. •What does CCS “0” mean? • One may still have non-calcifiedOne may still have non-calcified atherosclerotic plaque .atherosclerotic plaque . • Multiple studies have shown only a 0.11 %Multiple studies have shown only a 0.11 % annual event rate and 1.1% 10 year risk inannual event rate and 1.1% 10 year risk in asymptomatic patients with 0 CCS.asymptomatic patients with 0 CCS.
  • 26. •Advantages of CCS • Rapid .Rapid . • Does not require contrast.Does not require contrast. • Low radiation dose .Low radiation dose . • Reproducible.Reproducible. • Powerful prognostic data.Powerful prognostic data. • Disadvantages of CCS :Disadvantages of CCS : • CostCost • Radiation exposureRadiation exposure
  • 27. Coronary Calcium and Clinical OutcomesCoronary Calcium and Clinical Outcomes • OVERALL:OVERALL: – 15 studies published15 studies published – Age range 41- 85 years oldAge range 41- 85 years old – Approximately 15,000 patientsApproximately 15,000 patients – All studies have reported that coronaryAll studies have reported that coronary calcium predicts CV disease eventscalcium predicts CV disease events independently of and more accuratelyindependently of and more accurately than traditional risk factors.than traditional risk factors.
  • 28. • At 2004 a study was carried out inAt 2004 a study was carried out in Netherlands:Netherlands: • From 2,032 people ages 55 to 85, with aFrom 2,032 people ages 55 to 85, with a mean age of 77, who underwent CTmean age of 77, who underwent CT calcium scoring between 1997 and 2000calcium scoring between 1997 and 2000 • 0 -100 : 47%0 -100 : 47% • 100 -500 : 26%100 -500 : 26% • >500 : 27%>500 : 27% • The mean duration of follow-up was 2.7The mean duration of follow-up was 2.7 years, during which time 92 subjectsyears, during which time 92 subjects
  • 30. • Calcium scores 101-500 :Calcium scores 101-500 : double risk ofdouble risk of mortality.mortality. • Calcium scores over 500 :Calcium scores over 500 : 2.7 times2.7 times increased risk of mortality.increased risk of mortality. • The increase in mortality :The increase in mortality : between the lowest and the middlebetween the lowest and the middle category of calcium scores (0-100 and 101-category of calcium scores (0-100 and 101- 500) : 12.3%500) : 12.3%  between the middle and the highestbetween the middle and the highest scores (101-500 and >500) : 23.7%scores (101-500 and >500) : 23.7%
  • 31. Integrating the Calcium Score withIntegrating the Calcium Score with the Framingham Risk Score (FRS)the Framingham Risk Score (FRS) • 2004, Johns Hopkins University2004, Johns Hopkins University calculated the Framingham scores of 5,324calculated the Framingham scores of 5,324 asymptomatic individualsasymptomatic individuals • Stratified into low-risk, intermediate-risk, andStratified into low-risk, intermediate-risk, and high-risk groupshigh-risk groups ― Low-riskLow-risk is defined as a 10 year risk of < 10%,is defined as a 10 year risk of < 10%, ― intermediate-riskintermediate-risk is defined as a 10 year risk of 10is defined as a 10 year risk of 10 to 20%to 20% ― high-riskhigh-risk is defined as a 10 year risk > 20%is defined as a 10 year risk > 20% • Underwent CT coronary artery scanningUnderwent CT coronary artery scanning
  • 32. Framingham Score 10 yr. event riskFramingham Score 10 yr. event risk recalculated according to CCS rangerecalculated according to CCS range
  • 33. • CLASS IIaCLASS IIa • Measurement of CCS is reasonable forMeasurement of CCS is reasonable for cardiovascular risk assessment in asymptomaticcardiovascular risk assessment in asymptomatic adults at intermediate risk (10% to 20% 10-yearadults at intermediate risk (10% to 20% 10-year risk).risk). (Level of Evidence: B) .(Level of Evidence: B) . 2010 ACCF/AHA Guideline2010 ACCF/AHA Guideline RECOMMENDATIONS FOR CALCIUMRECOMMENDATIONS FOR CALCIUM SCORING METHODSSCORING METHODS
  • 34. • CLASS IIbCLASS IIb • Measurement of CCS may be reasonable forMeasurement of CCS may be reasonable for cardiovascular risk assessment in persons atcardiovascular risk assessment in persons at low to intermediate risk (6% to 10% 10-yearlow to intermediate risk (6% to 10% 10-year risk).risk). (Level of Evidence: B)(Level of Evidence: B) • CLASS III: NO BENEFITCLASS III: NO BENEFIT • Persons at low risk (<6% 10-year risk) shouldPersons at low risk (<6% 10-year risk) should not undergo CCS measurement fornot undergo CCS measurement for cardiovascular risk assessment.cardiovascular risk assessment. (Level of Evidence: B).(Level of Evidence: B).
  • 35. Detection of CAD/Risk Assessment inDetection of CAD/Risk Assessment in Asymptomatic Patients Without Known CADAsymptomatic Patients Without Known CAD IndicationIndication Appropriate Use Score (1–9)Appropriate Use Score (1–9) Global CHDGlobal CHD Risk EstimateRisk Estimate LowLow IntermediateIntermediate HighHigh Family history of premature CHD A (7)A (7) Asymptomatic No known CAD I (2)I (2) A (7)A (7) U (4)U (4) JCCT (2010) 4, 407.e1–407.e33JCCT (2010) 4, 407.e1–407.e33 ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI /SCMR 2010 Appropriate Use Criteria
  • 36. The 2013 ACC/AHA CholesterolThe 2013 ACC/AHA Cholesterol and the 2013 ACC/AHA Risk Guidelinesand the 2013 ACC/AHA Risk Guidelines • Created an entirely risk factor–basedCreated an entirely risk factor–based pooled cohort equation untested bypooled cohort equation untested by randomized clinical trials, using the samerandomized clinical trials, using the same risk factors as the 2010 version but withrisk factors as the 2010 version but with different weightings, now modified bydifferent weightings, now modified by race.race. • They downgraded CCS to a Class IIbThey downgraded CCS to a Class IIb recommendation.recommendation.
  • 37. ConclusionConclusion • Despite the remarkable data supporting the prime role of CCS in risk assessment of the intermediate-risk population & considering it a more potent predictor of CAD than risk factors for atherosclerosis , CCS has not been incorporated into the mainstream of clinical cardiology and has been downgraded in the 2013 guidelines. • As the data continue to accumulate with follow- up periods up to 15 years, accompanied by increasing public & physician awareness, the importance of CCS will be more universally accepted